Italy, L’Aquila 
Prof. Luciano Mutti is a globally recognized medical oncologist, translational scientist, and academic leader specializing in thoracic oncology and malignant pleural mesothelioma. With decades of experience across Europe and the United States, he is a pioneer in mesothelioma research, contributing to foundational discoveries in tumor biology, immunotherapy, and targeted treatments, as well as international clinical guidelines.
Current Position
- Professor of Oncology, University of L’Aquila
- Professor of Oncology, University of Buckingham
- Head of Medical Oncology Department, S. Salvatore Hospital, L’Aquila
- Director, ASL1 Abruzzo Oncology Network
Education
- PhD in Oncology, University of Turin
- MD, University of Genoa (Magna cum laude)
- Specialist Training in Respiratory Medicine and Pathophysiology, University of Genoa
Areas of Specialization
- Thoracic oncology
- Malignant pleural mesothelioma (MPM)
- Translational cancer research
- Immuno-oncology and immune checkpoint inhibitors
- Targeted therapies and antiangiogenic treatments
- Lung cancer and respiratory malignancies
Clinical & Research Focus
- Biology and treatment of mesothelioma
- Translational research bridging preclinical discovery and clinical trials
- Development of novel therapeutic strategies including immunotherapy and targeted agents
- Tumor immunology and microenvironment
- Biomarker-driven and precision oncology approaches
Leadership & Institutional Roles
- Former Chair in Cancer Research, University of Salford
- Adjunct Professor, Temple University
- Former Head of Translational Oncology Unit, Vercelli Teaching Hospital
- Director of Oncology Unit development at TTH Hospital
- Senior leadership roles across major UK and European oncology centers
Global Leadership & Scientific Contribution
- Founder member of the International Mesothelioma Interest Group (IMIG)
- Contributor to international mesothelioma and lung cancer guidelines
- Leader in establishing standards for thoracic oncology care in Europe
- Advisor to governmental and international scientific bodies
Academic Profile
- Extensive publication record in high-impact oncology journals
- Editorial board member and peer reviewer for leading journals including Cancer Research and PNAS
- Speaker and chair at major international oncology congresses
- Educator across undergraduate, postgraduate, and doctoral oncology programs
Innovation & Scientific Impact
- Pioneer in mesothelioma research since the early 1990s
- Led first studies supporting anti-angiogenic therapy in mesothelioma
- Contributed to early development of immune checkpoint inhibitor strategies
- Advanced translational models linking molecular biology to clinical therapies
- Directed multidisciplinary international research collaborations
Honors & Recognition
- Italian National Award for Research on Asbestos-Related Tumors
- “Scientist of the Year” (Piedmont College of Journalists)
- AACR International Research Prize
- Recognized among top thoracic oncologists in Italy
Teaching & Mentorship
- Professor and educator in oncology and cancer biology across Europe and the UK
- Supervisor of PhD, MSc, and medical students
- Leader in translational oncology education and multidisciplinary training
All information is sourced from publicly available materials.